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Osteoarthritis (OA), the leading cause of pain and disability world-
wide, disproportionally affects individuals with obesity. The mech-
anisms by which obesity leads to the onset and progression of OA
are unclear due to the complex interactions among the metabolic,
biomechanical, and inflammatory factors that accompany increased
adiposity. We used a murine preclinical model of lipodystrophy (LD)
to examine the direct contribution of adipose tissue to OA. Knee
joints of LD mice were protected from spontaneous or posttraumatic
OA, on either a chow or high-fat diet, despite similar body weight
and the presence of systemic inflammation. These findings indicate
that adipose tissue itself plays a critical role in the pathophysiology
of OA. Susceptibility to posttraumatic OA was reintroduced into LD
mice using implantation of a small adipose tissue depot derived from
wild-type animals or mouse embryonic fibroblasts that undergo
spontaneous adipogenesis, implicating paracrine signaling from fat,
rather than body weight, as a mediator of joint degeneration.
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Osteoarthritis (OA) is the leading cause of pain and disabilityworldwide and is associated with increased all-cause mor-
tality and cardiovascular disease (1, 2). OA is strongly associated
with obesity, suggesting that either increased biomechanical joint
loading or systemic inflammation and metabolic dysfunction
related to obesity are responsible for joint degeneration (1, 2).
However, increasing evidence is mounting that changes in bio-
mechanical loading due to increased body mass do not account
for the severity of obesity-induced knee OA (1–9). These ob-
servations suggest that other factors related to the presence of
adipose tissue and adipose tissue-derived cytokines—termed
adipokines—play critical roles in this process and other muscu-
loskeletal conditions (1, 2, 6, 7, 10). As there are presently no
disease-modifying OA drugs available, direct evidence linking
adipose tissue and cartilage health could provide important
mechanistic insight into the natural history of OA and obesity
and therefore guide the development and translation of novel
OA therapeutic strategies designed to preserve joint health.
The exact contribution of the adipokine-signaling network in OA
has been difficult to determine due to the complex interactions
among metabolic, biomechanical, and inflammatory factors related
to obesity (11). To date, the link between increased adipose tissue
mass and OA pathogenesis has largely been correlative (6, 7, 12),
and, as such, the direct effect of adipose tissue and the adipokines
it releases has been difficult to separate from other factors such as
dietary composition or excess body mass in the context of obesity,
which is most commonly caused by excessive nutrition (2, 6, 7). In
particular, leptin, a proinflammatory adipokine and satiety hor-
mone secreted proportionally to adipose tissue mass is most con-
sistently increased in obesity-induced OA (1), and leptin knockout
mice are protected from OA (6, 7). However, it remains to be
determined whether leptin directly contributes to OA pathogene-
sis, independent of its effect on metabolism (and weight). Addi-
tional adipokines that have been implicated in the onset and
progression of OA include adiponectin, resistin, visfatin, chimerin,
and inflammatory cytokines such as interleukin-1 (IL-1), IL-6, and
tumor necrosis factor-α (TNF-α) (13). The infrapatellar fat pad
represents a local source of adipokines within the knee joint, but
several studies indicate strong correlations with visceral adipose tis-
sue, outside of the joint organ system, with OA severity (14). Fur-
thermore, adipokine receptors are found on almost all cells within
the joint and, therefore, could directly contribute to OA pathogen-
esis through synovitis, cartilage damage, and bone remodeling (13).
The role of other adipokines (15) in OA pathogenesis remains to be
determined, as it has been difficult to separate and directly test the
role of adipokines from other biomechanical, inflammatory, and
metabolic factors that contribute to OA pathogenesis.
To directly investigate the mechanisms by which adipose tissue
affects OA, we used a transgenic mouse with lipodystrophy (LD)
that completely lacks adipose tissue and, therefore, adipokine
signaling. The LD model system affords the unique opportunity
to directly examine the effects of adipose tissue and its secretory
factors on musculoskeletal pathology without the confounding
effect of diet (16, 17). While LD mice completely lack adipose
tissue depots, they demonstrate similar body mass to wild-type
(WT) controls on a chow diet (12, 16–19). These characteristics
provide a unique model that can be used to eliminate the factor of
loading due to body mass on joint damage and, thus, to directly
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test the effects of fat and factors secreted by fat on musculoskel-
etal tissues. Of particular interest, LD mice also exhibit several
characteristics that have been associated with OA, including
sclerotic bone (11, 20), metabolic derangement (3, 5, 7–9, 21, 22),
and muscle weakness (2). Despite these OA-predisposing features,
LD mice are protected from OA and implantation of adipose tissue
back into LD mice restores susceptibility to OA—demonstrating
a direct relationship between adipose tissue and cartilage
health, independent of the effect of obesity on mechanical joint
loading.
Results
Male and Female LD Mice Demonstrate Metabolic Dysfunction and
Systemic Inflammation. On a chow control diet, both male and fe-
male LD mice demonstrated similar total body mass (Fig. 1A)
compared to their same-sex WT littermate controls. Body fat,
measured by both dual-energy X-ray absorptiometry (DXA) and
quantitative magnetic resonance technology (EchoMRI), was sig-
nificantly reduced in LD mice (Fig. 1B), while lean mass (Fig. 1C)
was similar, but liver mass was significantly increased in both male
and female LD mice (Fig. 1D) compared to WT mice. LD mice
lacked fat pads throughout the body, including the infrapatellar fat
pad normally found in the knee of WT mice (SI Appendix, Fig. S1).
To assess metabolic dysfunction, insulin-tolerance tests and
glucose-tolerance tests were performed. Insulin-tolerance tests
revealed overt insulin resistance in LD animals compared to WT
littermates, as evidenced by a significant increase in blood glu-
cose levels from baseline (Fig. 1E). A main effect of genotype
and interaction of genotype by sex was significant in glucose-
tolerance tests, but the area under the curve (AUC) was not
different between groups (Fig. 1F).
Systemic inflammatory profiles of male and female LD mice
indicated similar increases in the proinflammatory mediators IL-
1α, IL-1β, IL-6, TNF-α, macrophage chemoattractant protein-1
(MCP-1), and macrophage inflammatory protein-1α (MIP-1α)
(Fig. 1 G–L) compared to WT levels. However, LD mice also
demonstrated increased levels of the antiinflammatory mediators
IL-10, tissue inhibitor of metalloproteinases-1 (TIMP-1), and IL-
4 when compared to WT mice (Fig. 1 M–O). Negligible levels of
leptin were detected in serum from male and female LD mice
(Fig. 1P).
Chow-Fed LD Mice Demonstrate Reduced Activity and Muscle Weakness.
To phenotype the activity and metabolic characteristics of the LD
mice, we used indirect calorimetry over the period of 36 h (two
dark cycles). No sex differences were observed within each ge-
notype in any of the outcomes assessed. LD mice had reduced
oxygen consumption and energy expenditure (Fig. 2 A and B).
Consistent with a shift toward fat metabolism, LD mice demon-
strated a decreased respiratory exchange ratio (Fig. 2C) and re-
duced CO2 production when compared with WT control animals
(Fig. 2D). LD and WT mice consumed similar amounts of food
and water (Fig. 2 E and F) and exhibited similar energy balance
(Fig. 2G). LD mice, however, demonstrated decreased locomotor
activity (Fig. 2H) and ambulatory activity (Fig. 2I) compared to
WT mice over the observation period. Consistent with this re-
duced activity, LD mice exhibited significantly lower forelimb grip
strength when assessed at 16 and 28 wk of age (Fig. 2J). There was
a significant effect of sex and genotype, such that female mice of
both genotypes were weaker than their male counterparts. For
systemic inflammatory profiles of these animals, see SI Appendix,
Table S1.
LDMice Are Protected from Cartilage Damage and Pain-Related Behaviors.
Since LD mice show many characteristics that have been impli-
cated in the pathogenesis of knee OA, including subchondral bone
sclerosis, metabolic disturbance, inflammation, muscle weakness,
and decreased activity levels, we measured the severity of OA in
LD knee joints at 28 wk of age. Unexpectedly, LD mice exhibited
significantly reduced spontaneous knee joint damage in both male
and female animals, as measured by Modified Mankin Scores
(Fig. 3 A and D). Next, we challenged the LD animals with a
traumatic knee injury using destabilization of the medial meniscus
(DMM) surgery. In WT mice, both males and females demon-
strated significantly increased damage in DMM joints compared
to their nonsurgical contralateral limbs, although female WT mice
showed less severe OA as compared to male WT counterparts. In
contrast, both male and female LD mice were protected from
DMM-induced knee joint damage (Fig. 3 B and E). We observed
increased synovitis as defined by histology scoring in DMM knee
joints of LD mice compared to contralateral nonsurgical knees as
well as surgical and nonsurgical knee joints of WT mice (Fig. 3 C
and F). There was a trend toward increased osteophytes in DMM
limbs of both groups, but the main effect of surgery was not sig-
nificant (P = 0.07) (Fig. 3 B and G).
As sclerotic subchondral bone is widely implicated in OA onset
and pathogenesis, we assessed bone microstructure of LD mice
and compared it to WT mice using micro-computed tomography
(microCT) analysis. LD genotype, but not sex or surgery, drove
significant increases in male and female bone mineral density
(BMD) in the medial tibial plateau (Fig. 3 H and I). In addition to
genotype, a significant main effect of surgical intervention was
observed in medial tibial plateau bone volume/total volume (BV/
TV), and a significant interaction between sex and genotype was
seen. Tibial metaphysis BMD also demonstrated significant main
effects of sex and genotype. Tibial metaphysis BV/TV exhibited a
significant main effect of sex and genotype, and significant inter-
actions between sex × limb and sex × genotype were observed.
Trabecular thickness, trabecular number, BMD, and BV/TV for
the lateral tibial plateau, medial femoral condyle, and the medial
tibial plateau generally showed significant effects of genotype.
Detailed site-specific outcomes for each bone microstructure pa-
rameter were also described and compared (SI Appendix, Table
S2). Generally, LD mice demonstrate a strong increased bone
mass phenotype when compared to WT littermate controls.
We performed tests to quantify pain-related behaviors (i.e., knee
hyperalgesia and tactile allodynia) to evaluate if LD mice develop
increased pain sensitivity as a consequence of DMM despite an
absence of cartilage damage. LD mice exhibited significantly higher
paw-withdrawal thresholds when the DMM paw was subjected to an
Electronic Von Frey assay to determine tactile allodynia (Fig. 3J)
compared to WT animals. Furthermore, LD mice maintained
similar pressure-pain thresholds in both the surgical and nonsurgical
contralateral knee, while WT DMM knee joints demonstrated knee
hyperalgesia.
High-Fat Diet Does Not Exacerbate the Proinflammatory Profile of LD
Mice. A high-fat diet (HFD) has been shown to increase adiposity
and low-grade systemic inflammation that are associated with
cartilage degeneration and OA (1, 2). Given the inability of LD
mice to store fat, we next sought to determine if a HFD would
worsen the metabolic disturbance and inflammatory profiles ob-
served in LD mice and, therefore, override the protection we
observed in LD cartilage. Beginning at weaning, LD andWTmale
and female animals were fed either a 60% kilocalorie (kcal) from
fat diet or 10% kcal from fat chow diet. In WT mice, body mass
and body fat were increased with HFD. However, LD mice fed
HFD had no change in body mass or body fat and were similar to
LD and WTmice on a chow diet (Fig. 4 A and B). Lean mass at 28
wk was significantly reduced in both the LD and WT HFD-fed
animals (Fig. 4C) as compared to both genotypes on the chow
diet. Liver mass was elevated in LD mice compared to WT mice
but not significantly increased between chow and HFD (Fig. 4D).
In LD mice, a HFD did not worsen insulin tolerance in either
genotype, such that HFD LD and WT mice were similar to their
chow-fed WT counterparts (Fig. 4 E and F). Glucose tolerance,
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however, was significantly reduced in both LD and WT groups,
as demonstrated in the time-course and AUC values (Fig. 4E).
HFD did not further influence muscle weakness measured by
forelimb grip strength in LD mice but did reduce grip strength in
WT HFD-fed mice (Fig. 4F). Circulating leptin was increased in
HFD-fed WT animals compared to chow-fed WT, but leptin
remained undetectable in the serum of HFD-fed LD mice.
(Fig. 4G). HFD did not result in increased circulating proin-
flammatory mediators in LD mice, as levels for IL-1α, IL-1β, IL-
6, TNF-α, IP-10, and MCP-1 were similar to chow-fed LD levels
(Fig. 4 H–M). IL-10 and IL-4 remained elevated in LD animals
with HFD, whereas TIMP-1 was further elevated in HFD-fed
LD mice, such that it was increased compared to both chow-
fed LD mice and both WT groups (Fig. 4 N–P). For further
differences in serum profiles, see SI Appendix, Table S1.
HFD-Fed LD Mice Are Protected from OA. HFD has been demon-
strated to induce cartilage damage and OA in a manner that is
exacerbated by joint trauma (2–9, 23). Thus, we examined if high-
fat feeding could override the protection against joint damage
Fig. 1. Male and female LD mice demonstrate metabolic dysfunction and increased proinflammatory mediators in serum when compared to WT littermate
controls. (A–C) LD mice have similar body mass (A) but decreased body fat when measured by DXA and Echo MRI (B) and similar lean mass (C) to same-sex WT
littermates. (D and E) LD mice demonstrated increased liver mass (D), insulin-tolerance tests (E, Right), and AUC of insulin-tolerance tests (E, Left). (F) Glucose
tolerance demonstrated a significant main effect of genotype and genotype × sex. (G–O) Regardless of sex, LD mice demonstrated increased serum proin-
flammatory (IL-1α, IL-1β, IL-6, TNF-α, MCP-1, MIP-1α) and increased antiinflammatory mediators (IL-10, TIMP-1, and IL-4) compared to WT littermate controls.
(P) LD mice demonstrated near-zero levels of leptin in serum. P < 0.05 between groups is indicated by the letters “a” and “b” (n = 7 to 15 per group for A–F;
n = 3 for female WT; n = 4 to 7 for other groups for G–O serum outcomes; analysis by two-way ANOVA with Sidak or Tukey’s post hoc). ITT, insulin-
tolerance test.
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observed in chow-fed LD mice. Both male and female HFD-fed
LD mice remained protected from OA as assessed by Modified
Mankin Scores (Fig. 5 A and B). Both HFD-fed groups demon-
strated significantly increased osteophyte scores in the DMM
limbs (Fig. 5C). Synovitis scores were significantly increased in
chow-fed LD DMM limbs as compared to contralateral control
joints, and there was a trend toward a decrease in synovitis of
HFD LD DMM limbs (Fig. 5D). Significant negative Pearson
correlations were observed between serum levels of IL-10 (r2 =
0.42; P < 0.001), TIMP-1 (r2 = 0.38; P < 0.001), and IL-4 (r2 =
0.16; P < 0.035) and Modified Mankin Scores of histological knee
joint damage. No significant relations were observed between
proinflammatory mediators like IL-6 (r2 = 0.06; P = 0.22) and
Modified Mankin Scores.
As with chow-fed animals, genotype was the principal driver of
increased BMD and BV/TV in both the medial tibial plateau and
the tibial metaphyses (Fig. 5 E–G), as well as the lateral tibial
and femoral compartments (SI Appendix, Table S2). Medial
tibial plateau BV/TV also showed a significant main effect of
limb, and an interaction between limb × diet. Tibial metaphysis
BV/TV demonstrated significant main effects of limb in addition
to genotype, and significant interactions between limb × diet,
limb × genotype, and limb × diet × genotype. For additional
bone microstructure outcomes, see SI Appendix, Table S2.
LD animals fed chow and HFD were protected from hyper-
algesia, as measured by the decreases in paw-withdrawal thresh-
olds (Fig. 5H) and pressure-pain thresholds (Fig. 5I) observed in
WT animals. Despite consistent increases in IL-10 in serum of LD
mice on both diets, we did not observe changes in synovial fluid
(SF) levels for IL-10 (Fig. 5J). In WT animals, HFD feeding was
associated with increased SF TIMP-1 levels in the limb that un-
derwent DMM (Fig. 5K). There were significant decreases in SF
levels of leukemia inhibitory factor (LIF), TARC, and IL-12
(Fig. 5 L–N) in DMM limbs of LD mice. For SF profiles, see
SI Appendix, Table S3.
Transplantation of Adipose Tissue Restores Susceptibility to OA in LD
Mice. To determine if adipose tissue is a critical regulator of OA,
we transplanted adipose tissue into chow-fed LD mice using two
different methods. First, a mixture of subcutaneous and visceral
adipose tissue from WT mice was implanted subcutaneously on
the dorsum of LD mice (termed “WT fat-rescue”). A separate
cohort received cell-based injections of primary mouse embryonic
fibroblasts (MEFs) harvested from WT pregnant dams (termed
“MEF-rescue”). MEF injections, delivered subcutaneously to the
sternal aspect of mice, later regenerate a fat depot ∼21 d post-
injection, as previously described in this mouse model (18, 19).
Both groups of LD fat-transplant animals were challenged with
DMM surgery, and histological assessment revealed that both WT
fat-rescue and MEF-rescue animals demonstrated significant in-
creases in DMM joint damage when compared to nonsurgical
contralateral limbs. The severity of joint damage in either of the
fat-rescue LD mice was similar to DMM damage in WT control
animals (Fig. 6A), suggesting that fat implantation reintroduces
susceptibility to cartilage damage in LDmice. Fat implant size was
similar between groups (WT fat-rescue: 0.95 ± 0.1 g; MEF-rescue:
0.80 ± 0.07 g; P = 0.18), and mice receiving a fat implant main-
tained similar body mass with either WT fat-rescue (24.2 ± 0.7 g)
Fig. 2. LD mice fed a chow diet demonstrate reduced activity and muscle weakness, despite consuming similar amounts of food and water as WT controls.
(A–G) Using indirect calorimetry, LD mice demonstrate reduced oxygen consumption (A), energy expenditure (B), respiratory exchange ratio (C), and CO2
production (D) but similar hourly food (E), water (F), and overall average energy balance (G). (H and I) LD mice demonstrated lower locomotory (H) and
ambulatory (I) activity. No differences were observed by sex, so data were pooled by genotype for comparison. (J) A sex-specific deficit in forelimb grip
strength at 16 and 28 wk, operationalizing muscle strength, was observed in LD mice compared to WT controls. P < 0.05 between groups is indicated by the
letters “a,” “b,” and “c” (n = 7 to 16 per group; A–I, general linear modeling using the CalR web-based tool; (J), three-way ANOVA with Dunnet’s post hoc).
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or MEF-rescue (23.0 ± 0.2 g) mice as compared to the average
body mass of chow-fed LD (26.3 ± 1.2 g; by one-way ANOVA:
P = 0.12) mice. The size of the fat implant demonstrated a weak
correlation with Modified Mankin Score (r2 = 0.22; P = 0.0176)
when both rescue groups were considered together. When ana-
lyzed separately, the size of WT fat-rescue implant size demon-
strated no significant relationship with damage, while the MEF-
rescue group demonstrated a strong significant relationship with
implant size (r2 = 0.66; P < 0.001) with Modified Mankin Score.
Across all chow-fed animals, with and without transplant, there
was no significant correlation between body mass and Modified
Mankin Score (r2 = 0.028; P = 0.203).
Osteophyte scores were only increased in MEF-rescue LD
animals (Fig. 6A), while synovitis scores in the DMM limb were
increased in the LD group compared to WT and were rescued to
WT levels in the two transplant groups (Fig. 6A). Increases in
BMD were reversed to WT levels in the medial tibial plateau of
MEF-rescue LD animals, while BMD was similar in both limbs
from WT fat-rescue animals to LD mice (Fig. 6B). Medial tibial
plateau BV/TV was reversed to WT levels in MEF-rescue LD
mice but only in the DMM limb of WT fat-rescue mice (Fig. 6B).
Tibial metaphysis BMD was partially reversed to WT levels in
MEF-rescue animals but similar to LD mice in WT fat-rescue
mice (Fig. 6B). Tibial metaphysis BV/TV was reduced to WT
levels in the DMM limbs of both fat-transplanted groups, while
the nonsurgical contralateral limbs were similar to DMM limbs
in LD mice (Fig. 6B). For lateral tibial plateau, medial femoral
condyle, and lateral femoral condyle, as well as trabecular
thickness and trabecular number data, see SI Appendix, Table S2.
Knee hyperalgesia in response to DMM was restored in WT
fat-rescue and MEF-rescue LD animals to similar levels measured
in WT DMM limbs (Fig. 6C), while DMM limb paw-withdrawal
Fig. 3. LD mice are protected from spontaneous and posttraumatic OA. (A, B, D, and E) At 28 wk, both male and female LD mice demonstrated im-
provements in Modified Mankin Score (A and D) (black arrows indicate cartilage lesion) and, when challenged with DMM to induce posttraumatic OA,
demonstrated similar scores to their contralateral nonsurgical limbs (B and E) (black indicates nonsurgical contralateral limb; red indicates DMM limb). (B, C, F,
and G) LD male and female mice did demonstrate significant increases in synovitis post DMM (C and F) but similar osteophyte scores compared toWT controls.
(H) 3D bone renderings of surface and morphology reveal that LD andWT DMM limbs demonstrate boney outgrowth around the medial meniscus and thicker
trabeculae in LD mice at the tibial metaphysis (yellow arrows indicate areas of interest). (I) LD genotype drove increases in tibial plateau BMD and BV/TV, as
well BMD and BV/TV in tibial metaphyses. (J) LD mice demonstrated protections from the onset of paw allodynia on the DMM limb, measured by Electronic
Von Frey paw-withdrawal assay, and hyperalgesia at the knee, measured by SMALGO. Data were analyzed as two- or three-way ANOVA with either Sidak,
Tukey’s, or Dunnet post hoc (n = 5 to 15 per group). P < 0.05 between groups is indicated by the letters “a,” “b,” and “c.” gCaHA/cm3, grams of calcium
hydroxyapatite per cubic centimeter. Scale bar indicates 100 μm.
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threshold remained similar in both fat-transplant groups to the
values measured in LD animals (Fig. 6C). Forelimb grip strength
was also restored in both WT fat-rescue and MEF-rescue animals
(Fig. 6C).
Several aspects of the systemic metabolic profiles were im-
proved in both MEF- and WT fat-rescue animals. Reduced lo-
comotor activity was also reversed in both fat-transplant groups,
such that both rescue groups showed activity profiles that were
similar to WT animals and were significantly increased compared
to LD animals (Fig. 6D). Insulin-tolerance curves were signifi-
cantly reduced in both WT fat-rescue and MEF-rescue groups,
but the AUC of these curves remained similar to the AUC of LD
mice (Fig. 6 E and F). Glucose-tolerance curves were significantly
improved in WT fat-rescue animals, but curves from MEF-rescue
animals were similar to WT and LD animals (Fig. 6G). Serum
leptin was restored in both MEF-rescue and WT fat-rescue LD
mice, to ∼20 to 30% of endogenous circulating levels in WT mice
(Fig. 6H).
Fat transplantation reduced the circulating levels of antiin-
flammatory mediators IL-10 and TIMP-1 in LD mice to WT levels
(Fig. 6I). Proinflammatory mediators IL-6, TNF-α, and IL-1α were
also reduced in WT fat-rescue and MEF-rescue animals, but IL-17
was significantly increased when compared to both LD and WT
treated animals (Fig. 6I). Serum levels for IL-10 demonstrated a
Fig. 4. HFD feeding of LD mice does not increase the metabolic derangement. (A and B) Body mass (A) and body fat (B) over time were only increased in WT
animals fed HFD but not LD fed HFD. (C and D) Lean mass was decreased in both groups fed HFD (C), but liver mass was increased in LD mice to a similar extent
even on HFD when compared to WT (D). (E) Insulin resistance by insulin-tolerance test was not affected by HFD, and differences were only observed by
genotype, as in the AUC. Glucose sensitivity was reduced by HFD, as indicated in the AUC. (F) Muscle weakness was also decreased in LD mice and, at 28 wk,
decreased in HFD-fed WT animals when compared to their 16-wk time point. (G) Serum leptin was increased in WT animals fed HFD but still completely absent
in LD mice regardless of diet. (H–M) Levels of proinflammatory mediators that were elevated in LD mice were not further elevated by HFD (IL-1α, IL-1β, IL-6,
TNF-α, IP-10, MCP-1). (N–P) Levels of antiinflammatory mediators IL-10 and IL-4 were similarly not increased by HFD in LD mice, but TIMP-1 was significantly
increased. Data were analyzed as two- or three-way ANOVA with either Sidak, Tukey’s, or Dunnet post hoc (n = 10 to 18 per group). P < 0.05 between groups
is indicated by the letters “a,” “b,” and “c.” GTT, glucose-tolerance test; ITT, insulin-tolerance test.
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modest, but significant, negative relationship with Modified Mankin
Score when the fat-transplanted animals were included in the cor-
relation analysis (r2 = 0.26; P < 0.001). For serum differences due to
fat transplantation, see SI Appendix, Table S4.
Despite the alterations we observed in the serum profiles of fat-
transplant animals, we did not observe any differences in IL-10
concentration in the SF (Fig. 6J). SF levels for TIMP-1 in MEF-
rescue animals were similar to those observed on contralateral and
DMM limbs of WT mice; however, WT fat-rescue SF levels of
TIMP-1 were decreased in both limbs, such that they were similar to
the levels observed in the WT contralateral limb (Fig. 6J). Levels for
IL-6 were significantly increased in both fat-transplant groups
Fig. 5. HFD feeding does not override protection from posttraumatic OA in LD mice. (A and B) WT HFD-fed male and female animals demonstrated increased
Modified Mankin Scores when compared to both chow WT DMM limbs and contralateral nonsurgical controls (black indicates nonsurgical contralateral limb;
red indicates DMM limb). Regardless of diet or DMM surgery, LD mice demonstrated similar Modified Mankin Scores to their nonsurgical contralateral limbs.
(C) HFD-fed LD mice did demonstrate a trend toward a reduction in synovitis in the DMM limb. (D) Both HFD WT and LD mice demonstrated increased
osteophyte scores in the DMM limb. (E) 3D bone images from knee joint microCT and trabeculae from tibial metaphysis, bony outgrowth, and trabecular
thickness (areas of interest indicated with yellow arrows). (F and G) Genotype drove the differences in BMD and BV/TV of medial tibial plateau and tibial
metaphyses. (H and I) LD mice on both diets demonstrated protection from reduced paw-withdrawal threshold measured by Electronic Von Frey, and the
onset of knee joint hyperalgesia measured by SMALGO, compared to WT controls in DMM limbs. (J and K) SF levels for antiinflammatory mediators IL-10 and
TIMP-1 were similar by joint, genotype, and diet. (L–N) Reductions were observed in DMM LD joint SF levels for LIF and TARC. For remaining SF profiles, see SI
Appendix. Data were analyzed as two- or three-way ANOVA with either Sidak, Tukey, or Dunnet post hoc tests (n = 10 to 18 per group). P < 0.05 between
groups is indicated by the letters “a,” “b,” and “c.” gCaHA/cm3, grams of calcium hydroxyapatite per cubic centimeter. Scale bar indicates 100 μm.
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Fig. 6. Transplantation of fat restores susceptibility to OA damage and partially corrects the metabolic derangement in LD mice. (A) Both WT mature adipose
(WF-R) transplant and primary mouse embryonic fibroblast (MEF-R) transplant in LD mice restores increased Modified Mankin Scores in DMM limbs (black
arrows indicate areas of cartilage damage and proteoglycan loss; black symbols indicate nonsurgical contralateral limb, red symbols indicate DMM limb).
Osteophyte scores were significantly increased in MEF-rescue animals compared to the other groups in DMM limbs. Synovitis scores were similar across groups
in DMM limbs. (B) Medial plateau BMD and BV/TV in contralateral limb were reduced to WT levels in MEF-rescue animals only; WT fat-rescue animals’ DMM
limbs demonstrated significant reductions in BV/TV to WT levels. (C) Both transplant types restored susceptibility to knee hyperalgesia but not paw allodynia
in the DMM limb; forelimb grip strength was also restored to WT levels in both transplant groups. (D) Restoration of activity levels was also observed in both
transplant groups. (E and F) While both fat transplant groups demonstrated overall improvements in insulin resistance, the AUC was not significantly dif-
ferent from the LD mice. (G) WT fat-rescue, however, significantly improved glucose tolerance. (H) Leptin ELISA demonstrated that both fat transplant groups
reintroduce circulating leptin levels to LD mice. (I) Serum levels for IL-10 were reduced in both transplant groups compared to LD mice, but serum TIMP-1 was
only reduced in WT fat-rescue mice. Other proinflammatory mediators (IL-6, TNF-α, IL-1α) were also improved in transplant mice, whereas IL-17 was sig-
nificantly elevated. (J) SF levels for IL-10 were similar across groups, whereas TIMP-1 levels in the DMM limbs were elevated to WT levels in MEF-rescue LD
mice. SF levels for IL-6 and IL-1α were increased in WT fat-rescue and MEF-rescue animal DMM limbs. Data were analyzed as one-, two-, or three-way ANOVA
with either Sidak, Tukey’s, or Dunnet post hoc tests (n = 7 to 18 per group). P < 0.05 between groups is indicated by the letters “a,” “b,” and “c.” gCaHA/cm3,
grams of calcium hydroxyapatite per cubic centimeter; ITT, insulin-tolerance test. Scale bar indicates 100 μm.
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compared to LD and WT limbs, whereas SF IL-1α levels were
decreased in LD DMM limbs but similarly increased in the limbs of
both of WT fat-rescue and MEF-rescue LD animals (Fig. 6J). For a
list of SF changes in WT fat-rescue and MEF-rescue animals, see
SI Appendix, Table S5.
Discussion
While several studies have intimated relationships between adi-
posity, low-level systemic inflammation, and OA, the direct role
of adipose tissue on cartilage health has been difficult to ascertain
(1–4, 6–9, 22, 24–26). Herein, we demonstrate that knee joints
from mice lacking adipose tissue are protected from spontaneous
or injury-induced OA, even when fed a HFD. Because increased
pain and hyperalgesia are the primary clinical symptoms of OA
(27), we also assessed two pain-related outcomes: knee hyper-
algesia and tactile allodynia, in addition to structural OA. We
observed that LD mice are also protected from the onset of these
pain-related outcomes with DMM, consistent with protection
against structural damage. Remarkably, the transplantation of a
small amount of adipose tissue mitigated or reversed these con-
tributing factors (low-level systemic inflammation, metabolic dis-
turbance, insulin resistance, sclerotic bone, muscle weakness,
reduced activity) and restored susceptibility to cartilage damage
and knee hyperalgesia in transplanted LD mice. Furthermore,
these data support the notion that OA can be influenced and
controlled by tissues outside of the joint organ system, as the ad-
dition of metabolically healthy fat can restore susceptibility in OA-
resistant animals. This controlled model of LD confirms a direct
relationship between adipose tissue and the onset and progression
of OA, independent of biomechanical and metabolic contributors,
although the specific factors involved in this protection remain to
be clarified. Importantly, this model provides a system that will
allow us to disentangle the contributions of specific adipokines to
cartilage damage via this adipose–cartilage signaling axis.
The protection from cartilage damage observed in LD mice
suggests that proinflammatory mediators released from adipose
tissue could serve as therapeutic targets for OA. Adipose tissue
may promote OA susceptibility directly through adipokine sig-
naling, triggering systemic inflammation that ultimately mani-
fests locally within the joint, although the exact mechanism by
which this happens remains to be determined. Indeed, increased
leptin levels have been consistently reported in obesity-induced
OA (6, 7, 28, 29), potentially in response to leptin resistance (2),
and may be responsible for driving OA-associated inflammation
(29). Furthermore, leptin knockout mice are protected from OA
(6, 7), consistent with the phenotype of LD mice in this study,
which completely lack leptin. We observed that metabolic de-
rangement and adipokine signaling can be rescued in the LD
mice by the implantation of a surrogate fat pad derived from a
MEF cell-based injection, or through mature adipose tissue im-
plantation (5, 15), that restores between 20 to 30% of normal
leptin levels in LD-transplanted mice. However, previous studies
showed that inhibition of leptin failed to treat OA in the clinical
setting, and directly exposing cartilage explants to leptin did not
induce cartilage damage (6). Therefore, it is possible that the
critical mediator involved in promoting OA in the LD mouse
following fat transplant is downstream of leptin. Ongoing studies
will further elucidate the specific role of this adipokine.
LD mice demonstrate consistently higher serum levels of proin-
flammatory mediators (e.g., IL-1α, IL-1β, IL-6, TNF-α, MCP-1, IP-
10). We speculate that increased proinflammatory mediator levels
are related to the hepatic steatosis pathology (30), which has pre-
viously been observed in LD mice (12), that is also observed in the
present study via the large increases in liver mass in LD mice. We
postulate that the strong proinflammatory profiles in LD mice can
help separate the contribution of adipokines from other mediators
related to metabolic disturbance or liver pathology in this context.
Our future efforts hope to determine the exact contribution of liver
pathology to these serum inflammatory profiles.
LD mice, however, also demonstrate high levels of various
antiinflammatory mediators (IL-10, TIMP-1, IL-4). IL-10, a
potent antiinflammatory molecule that is negatively associated
with cartilage damage, has been proposed as an OA therapeutic
and pain reliever (31, 32). Due to structural homology, IL-10 can
substitute for leptin (33) and reduces insulin resistance and
HFD-induced inflammation in models of obesity without off-
target proinflammatory consequences (34). In fat- or MEF-
rescue LD mice, we saw a decrease in circulating serum levels
of IL-10, which could potentially explain the reversal of cartilage
protection observed in nontransplanted LD mice. IL-10 is known
to induce TIMP-1 and reduce the activity of matrix metal-
loproteinases (35). IL-10 may drive the increases in TIMP-1 seen
in serum and SF of LD mice. However, increases in TIMP-1 alone
does not protect against OA phenotype. Future work will deter-
mine if sustained increases in circulating levels of IL-10 is indeed a
key protective mechanism against cartilage damage in LD mice.
Adipose transplantation increased circulating levels of IL-17,
an inflammatory cytokine previously implicated in OA patho-
genesis (36). IL-17 has been shown to regulate adipogenesis,
glucose homeostasis, and obesity (37). Whether fat or MEF
transplant directly produces IL-17 or, more likely, stimulates IL-17
production from host cells (38) remains to be determined. How-
ever, studies have previously shown that the MEFs delivered as a
cell-based therapy ultimately form a tissue that integrates well into
the host (18, 19). Thus, the IL-17 increases observed in MEF-
rescue and WT fat-rescue animals may reflect the integration
and lipid storage that results from implantation in LD mice. Ul-
timately, IL-17 could be a key factor contributing to the restora-
tion of OA susceptibility in LD mice upon fat transplant, as others
have reported IL-17 as a potential biomarker for a distinct subset
of inflammatory OA patients with end-stage disease (39).
It is important to note that LD mice also lack other signaling
molecules, such as adipsin, or complement factor D, which
cleaves factor B to initiate alternative complement-pathway ac-
tivity (12). Previous studies have demonstrated a protective ef-
fect of adipsin deficiency on both spontaneous and posttraumatic
OA pathogenesis (15, 40), so it is unclear whether adipsin defi-
ciency protects against joint damage in the present studies. Our
ongoing work is interrogating the role of adipsin-knockout ani-
mals in the presence of HFD and OA to determine if the absence
of adipsin signaling in particular protects against cartilage damage
in the LD mouse.
Synovitis has been associated previously with HFD-induced
OA (5, 8, 9, 22, 41). Here, we observed increased synovitis in
LD mice, in addition to several differences in SF cytokine con-
centrations that are generally consistent with OA pathogenesis
(36). However, we did not observe overt structural damage to
LD knee joint cartilage in these mice, suggesting that the factors
driving synovial inflammation are separable from those driving
changes in cartilage structure and loss in OA. Specifically, in SF,
we observe reduced levels for LIF and IL-12 in the DMM limbs
of LD mice and a concordant increase in IL-1α and IL-6 in
MEF-rescue and WT fat-rescue LD mice. This implicates a role
for the IL-1 and IL-6/IL-12 family of cytokines in protection and
susceptibility to OA, which have been postulated as key thera-
peutic target networks for OA (36). Notably, we did not see a
reversal of synovitis in MEF-rescue and WT-fat rescue animals,
which may be either contributing to or in response to this increase in
SF IL-1α and IL-6. Moreover, we observed decreased levels for
TARC/CCL-17 in LD DMM limbs, which is of interest as CCL-17
blockade has been demonstrated as a therapeutic candidate for OA
structure and pain (42). In the fat-rescue groups, we observed in-
creased circulating levels of TARC/CCL-17 but decreased SF levels
for TARC/CCL-17. IL-4 is another promising antiinflammatory
candidate for cartilage protection under active investigation, and,
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here, we observed increased IL-4 in LDmice (43). However, as IL-4
can also induce TARC/CCL-17 via STAT6, this may offset the
therapeutic effect of IL-4 overexpression (44). Future studies will
evaluate the direct influence of IL-6/IL12 axis and TARC/CCL-17
signaling in the protection from OA in LD mice.
A striking absence of antiinflammatory signatures were found
in the SF of LD mice when compared to WT mice, which may
also be consistent with the increased synovitis we observed in LD
mice. There are a few plausible explanations for this finding.
First, evaluating data cross-sectionally at the terminal end point
of 12 wk post-DMM does not allow for temporal assessment of
changes in the systemic or local inflammatory environment, and
it is possible that critical changes in the SF that contribute to
cartilage protection occur soon after DMM and are not detect-
able at the terminal end point. A second possibility is that the
systemic environment, which is directly affected by the absence
and implantation of adipose tissue, is mitigating and driving OA
disease pathogenesis in this LD model system. This proposition
is consistent with several studies that demonstrate increased
body mass per se does not explain obesity-associated knee OA
but that, in fact, associations with systemic proinflammatory
mediators and other tissues (e.g., muscle) provide robust asso-
ciations with OA pathogenesis (1, 4, 6, 7, 28, 29), which is the
opposite of what we observed in the LD mice. As such, we
postulate that the strong antiinflammatory signature evidenced
in LD mice, which is reversed upon adipose implantation, is a
key driver of this protection and that systemic overexpression of
antiinflammatory mediators may be a useful therapeutic ap-
proach for chondroprotection with injury or obesity. However, it
is important to note that the source of these cytokines may in-
fluence their effect on joint tissues. For example, it has been
hypothesized that the infrapatellar fat pad, which is absent in LD
mice, may serve as a local source of intraarticular adipokines
mediating knee OA (26, 28). In addition, many of the proin-
flammatory mediators that are increased in LD mice can be
produced in other tissues, such as the liver, which shows in-
creased size and pathology in this model (12). Increased liver fat
is associated with increased circulating levels of proinflammatory
mediators in serum (45), including IL-6, even when adjusted for
BMI and visceral fat content. Further work is needed to deter-
mine the specific signals and mediators secreted from adipose
tissue that drive OA pathogenesis.
An important finding in these studies is the remarkable pres-
ence of bone sclerosis in concordance with healthy cartilage in
LD mice, which was subsequently reversed with fat transplan-
tation. Many studies have hypothesized that subchondral scle-
rosis is a pathological characteristic of and key contributor to OA
(11, 20), even proposing that subchondral bone remodeling is a
primary driver of cartilage damage (20). However, our findings
clearly demonstrate that these factors are biologically separable,
and healthy cartilage can persist even when challenged with
trauma, in the presence of marked subchondral sclerosis and
increased bone density throughout the joint. Similarly, the re-
versal of muscle weakness observed in LD mice with fat im-
plantation contradicts many studies that have suggested a key
role for muscle weakness in the pathogenesis of OA (2, 8). This
includes recent work from our laboratory that demonstrates risk
for posttraumatic OA can be mitigated by enhancing muscle
structure and strength and correcting metabolic derangement
using a gene therapy approach (5). Future studies will aim to
resolve these issues and disentangle these risk factors for obesity
and OA using the LD mouse platform and time-course studies.
These insights may contribute to our evolving understanding of
mechanical and biological tissue cross-talk, both within and be-
tween the joint organ system, including whether cartilage can
feed back and signal to adipose tissue. These lines of inquiry will
help determine what constitutes compensatory versus patholog-
ical loading and inflammatory environments. Using this insight,
we can begin to unravel intrinsic mechanisms that other tissues
of the joint organ system or other tissues external to the joint
may employ in efforts to protect cartilage in situations of trauma
or challenge. These data can facilitate clarity around critical
drivers, likely derived from adipose tissue, which may be foun-
dational in the onset of obesity- or joint injury-induced OA as
well as form the basis for novel therapeutic strategies.
LD mice showed reduced activity as compared to the WT mice,
and this phenotype was reversed by fat transplantation. While the
relationship between OA and activity is complex, we and others
have found that increased joint loading due to exercise is pro-
tective against joint damage with obesity (46–48). However, we
also observed decreased muscle strength in LD mice, prior to
DMM surgery, which is strongly related to decreased activity and
widely implicated in OA onset and progression (2), but observe
cartilage protection in LD mice. Another recent study in our
laboratory demonstrated that protection of muscle strength and
function using systemic overexpression of follistatin via gene
therapy protected mice from HFD-induced cartilage damage with
DMM (5). These findings indicate the complex interplay among
muscle strength, activity, adipose signaling, and joint loading in the
context of OA, which can hopefully be addressed in future studies
using this model.
Conclusion
Adipose tissue is a critical antagonist of cartilage health and in-
tegrity independent of body mass, systemic inflammation, synovi-
tis, muscle weakness, and subchondral bone sclerosis. Specifically,
these data implicate several context-relevant therapeutic targets: a
joint/cartilage protective role conferred by systemic increases in
IL-10 and TIMP-1 or inhibition of IL-6/IL-12, leptin, IL-17, and
CCL-17 axes. Characterizing adipose–cartilage cross-talk and
signaling may lead to novel therapeutic opportunities for OA as
well as other metabolic diseases involving adipose dysfunction.
The LD mouse provides a powerful tool to disentangle the
mechanisms involved in cartilage protection and vulnerability, and
our ongoing efforts aim to clarify these mechanisms by interro-
gating specific adipokines/cytokines identified in the present study.
Materials and Methods
Animals and Design. All experimental procedures were approved by the In-
stitutional Animal Care and Use Committee and were carried out in accor-
dance with the guidelines prescribed by the Washington University School of
Medicine Department of Comparative Medicine. LD mice and WT littermate
controls were developed by crossing adiponectin-Cre mice with homozygous
lox-stop-lox-ROSA-diphtheria toxin A mice on a C56BL/6 background (1) and
were maintained at thermoneutrality throughout their lifespan (30 °C).
Male and female offspring were weaned at 4 wk of age to either a chow
diet (13% fat; 29% protein; 60% carbohydrate; energy density, 3.0 kcal/g)
(standard chow) or HFD (60% fat; 20% protein; 20% carbohydrate; energy
density, 5.2 kcal/g) (D12492; Research Diets) ad libitum through 28 wk of age
(n = 7 to 16 per group). Mice were group-housed such that n = 3 to 5 per
cage, and genotypes were mixed within a given cage. For the timeline of
these studies, see SI Appendix, Fig. S1. In the transplantation studies, male
and female LD mice received either a MEF transplant (MEF-rescue) (19),
between 3 and 5 wk of age, or WT fat transplant containing visceral and
subcutaneous fat (WT fat-rescue) (16, 17), between 6 and 8 wk of age. At 16
wk, surgical animals underwent surgery for DMM in their left knee joints,
and the right limb served as a nonsurgical contralateral control (5, 8, 9, 49).
Behavioral and metabolic assays were conducted throughout the course of
this study. Mice were sacrificed at 28 wk of age to assess OA severity, bone
microstructure, and serum and SF inflammatory profiles.
Body Weight and Composition. Mice were weighed weekly throughout the
course of the study. Body fat was measured by DXA (Lunar Piximus) at 15 and
27 wk of age. In a subset of animals, an Echo MRI 3-in-1 instrument (Echo
Medical Systems) was used to quantify body fat.
Fat Transplantation. MEFs were harvested from E14 C57BL/6J embryos, resus-
pended in phosphate-buffered saline (PBS), and delivered as a subcutaneous
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injection on the sternal aspect of the animals, as described previously (19).
Embryos were isolated immediately after the pregnant dams were cervically
dislocated. The liver, heart, and intestine were removed from decapitated
embryos, and the remaining tissue was minced and digested in 1.25 mL of
0.05% trypsin for 45 min in a 37 °C water bath. Trypsin was neutralized with a
mixture of Dulbecco’s Modified Eagle medium, 1% penicillin-streptomycin, and
10% fetal bovine serum, triturated vigorously by pipetting up and down ∼30
times, and filtered using a 70-μm cell strainer. The filtrate was then centrifuged
at 500 × g for 6 min, and the cell pellet was resuspended in 250 μL of PBS. The
injection was delivered using a 27-gauge insulin syringe into a donor LD mouse
that was 3 to 5 wk old and anesthetized under 2 to 3% isoflurane.
Mature fat depots were implanted in accordancewith previously described
methods (16, 17). Donor WT mice (6 to 8 wk old) were euthanized, and
subcutaneous and visceral fat pads were harvested and cut into 100- to
150-mg pieces, in PBS on ice. Recipient mice were anesthetized using 2 to
3% isoflurane, dorsal hair was shaved, fat was implanted (∼1 g/mouse), and
incisions were closed with absorbable sutures.
Posttraumatic OA Induction by DMM. At 16 wk of age, mice were challenged
with unilateral DMM on their left knee joint, in accordance with previously
described methods (9, 49). Briefly, anesthetized mice were positioned su-
pine in a custom-designed device that maintained 90° of knee flexion in
the left knee. The medial meniscotibial ligament was approached from the
medial aspect of the knee by creating a small incision in the skin, followed
by an incision in the joint capsule, and ultimately transected. The joint
capsule and skin were closed by absorbable sutures and Vetbond (3M, Inc.)
skin glue.
Histological Assessment of OA, Synovitis, and Osteophytes. At 28 wk of age, 12
wk post-DMM surgery, mice were euthanized and knee joints were assessed
using histology. Knee joints were harvested, and all excess tissue and muscle
were trimmed and fixed in 4% paraformaldehyde for 24 h. Limbs were
decalcified in 10% formic acid (Cal-Ex) for 72 h, dehydrated, processed, and
embedded in paraffin blocks. Serial frontal plane sections were cut at 5 μm
and stained with either hematoxylin, fast green, and safranin O (saf-O/fast
green) or hematoxylin and eosin (H&E). Saf-O/fast green slides were scored
using Modified Mankin Criteria to operationalize knee joint damage (5, 9).
This scoring system employs a 30-point scale for four compartments of the
frontal plane section (medial tibial plateau, lateral tibial plateau, medial
femoral condyle, lateral femoral condyle), which is added to generate the total
Modified Mankin Score for a joint that serves as the semiquantitative measure
for joint damage. To assess synovitis in these joints, H&E-stained slides were
graded for synovial stroma density (0 to 3) and synovial lining thickness (0 to 3)
for all four compartments of the synovium in the joint, corresponding to the
four regions assessed in the Mankin Score. These values were summed to
provide a total semiquantitative measure of synovitis (5, 9). Finally, to deter-
mine whole joint osteophytosis, the same four quadrants of each knee joint
were graded from 0 to 3 using previously described methods (9) and summed
for a cumulative score per joint. All histological scores represent the average
values from scores of three blinded graders, and the interrater reliability
measured by intraclass correlation was r > 0.90 (P < 0.001).
Bone Microstructural Analysis. Whole knee joints were scanned by micro-
computed tomography (Bruker SkyScan1176) at a resolution of 18-μm iso-
tropic voxel resolution according to previously reported methods (5, 8). To
reduce beam hardening, a 0.5-mm aluminum filter was used during scan-
ning. Hydroxyapatite calibration phantoms were scanned to calibrate bone
density. Scans were reconstructed to three-dimensional (3D) images using
NRecon software, and CTAn software was used to segment subchondral and
trabecular regions from the medial tibial plateau, lateral tibial plateau,
medial femoral condyle, and lateral femoral condyle for analysis. The tibial
epiphysis was identified using the subchondral plate and growth plate as
references. The tibial metaphysis was defined as the 1-mm area directly
below the growth plate. The main outcomes reported from microCT images
are BMD, BV/TV (%), trabecular number, and trabecular thickness.
Serum and SF Profiling. All mice were fasted prior to sacrifice. Serum was
collected ina serum separator tube and allowed to clot at room temperature. SF
was collected using an alginate pad that was digested in alginate lyase until a
stop solution was applied (5, 8). Both fluids were stored at −80 °C until analysis
by Luminex multiplex 44-plex chemokine/cytokine array assay (Eve Technolo-
gies). The 44-plex assay included eotaxin, erythropoietin, 6Ckine, fractalkine,
G-CSF, GM-CSF, IFNB1, IFNγ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10,
IL-11, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-16, IL-17, IL-20, IP-10, KC, LIF, LIX,
MCP-1, MCP-5, M-CSF, MDC, MIG, MIP-1α, MIP-1β, MIP-2, MIP-3α, MIP-3B,
RANTES, TARC, TIMP-1, TNF-α, and VEGF. Serum was assessed at a dilution of
1:2, and SF was evaluated at a dilution of 1:75 based on the minimum con-
centration of 75 μL.
Enzyme-linked immunosorbent assay (ELISA) for serum leptin was con-
ducted using a mouse/rat Leptin Quantikine ELISA Assay kit (MOB00; R&D
Systems) at a dilution of 1:2 in LD mice, and all other groups were evaluated
at the manufacturer’s recommended 1:20 dilution. The lower limit of de-
tection of the assay was 22 pg/mL, and the interassay variability was 3 to 4%.
Insulin- and Glucose-Tolerance Tests. Insulin- and glucose-tolerance tests were
performed 4 wk post-DMM surgery (20 wk of age) after fasting mice for a
minimum of 4 h. Each test was conducted at least 1 wk apart in all animals.
For both tests, fasting glucose levels were measured by tail bleed at time
point 0 to establish a baseline. For glucose-tolerance tests, animals were
administered 1 mg/kg (10% dextrose: 1% volume/body mass) by intraperi-
toneal (IP) injection, and for insulin-tolerance tests, 0.75 U/kg body mass of
insulin (Humulin R diluted to 75 mU/mL, 1% volume/body mass) was ad-
ministered by IP injection (19). Serial blood glucose measurements were
taken via tail vein at 20, 40, 60, and 120 min after injection with a glucose
meter (Contour; Bayer).
Metabolic Parameters. Indirect calorimetry and activity were measured over
36 h after a 6-h acclimatization period using a Phenomaster (TSE Systems)
Metabolic Caging System at room temperature (22 °C) at 22 to 24 wk of age.
Each mouse was individually housed during the observation period and given
free access to food and water. Data were analyzed using the CalR web-based
tool for indirect calorimetry experiments (50) using the two-group or four-
group templates and one-way ANOVA with Tukey’s post hoc test.
Pain-Related Assessments and Behavioral Testing. All animals were acclima-
tized to all equipment 1 d prior to the onset of testing. Forelimb grip strength
was used tomeasuremuscle strength both prior to DMM at 15wk of age and,
prior to sacrifice at 27 wk of age, using a Chatillon DFE Digital Force Gauge
(Johnson Scale Co.). Each mouse was evaluated five times with a minimal
resting period of 90 s between trials, and these trials were averaged to
determine the grip-strength value for each mouse. Two measures for pain
were conducted at 27 wk of age. To assess tactile allodynia in the DMM limb,
an Electronic Von Frey assay was used. Mice were placed individually in
acrylic cages (12 × 10 × 17 cm high) with a wire grid floor. Hind paws of
DMM limbs were stimulated two to three times. A hand-held force trans-
ducer with a 0.5-mm 2-polypropylene tip (Electronic Von Frey anesthesi-
ometer; IITC Life Sciences) was used to apply force against the central aspect
of the DMM hind paw. The intensity of the stimulus (grams) was recorded by
the tester when the paw was withdrawn. The stimulation of the paw was
repeated until the animal presented three similar measurements. To assess
mechanical hyperalgesia, pressure-pain tests were conducted using a Small
Animal Algometer (SMALGO) (Bioseb) (5). Three trials of the surgical and
nonsurgical limb were collected by applying a steadily increasing force to
the lateral aspect of each limb until the limb was withdrawn. The average of
three trials for each limb was reported, and maximum value of 450 g was
employed to avoid tissue damage to the knee joint.
Statistical Analysis. Statistical analysis and number of animals per group for
each experiment are described in each figure legend. Analysis was performed
in Graphpad Prism 8 (Graphpad Software) or SPSS Statistics 23 (IBM). A priori α
was defined as 0.05. Data are presented as means ± SE and were compared
by either one-way, two-way (group × limb; genotype × sex; genotype ×
diet), or three-way (limb × genotype × diet; limb × genotype × sex) ANOVA
with Dunnet, Sidak, or Tukey’s post hoc test.
Data Availability.All data needed to evaluate the conclusions in the paper are
present in the article and SI Appendix.
ACKNOWLEDGMENTS. We thank Natalie Kelly and Erica Ely for assistance
with behavior-testing experiments and Sara Oswald for assistance with editing
and figure composition. This work was funded by the Shriners Hospitals for
Children, Musculoskeletal Research Center Pilot Grant P30 AR074992, and
Feasibility and Just-In-Time Grant Program Grants T32 DK108742 and T32
DK007120. This study was supported, in part, by NIH Grants AR50245,
AG15768, AG46927, AR076820, AR073752, and OD10707; the Arthritis Foun-
dation; and the Nancy Taylor Foundation for Chronic Diseases.
Collins et al. PNAS | 11 of 12








1. F. Berenbaum, T. M. Griffin, R. Liu-Bryan, Review: Metabolic regulation of inflam-
mation in osteoarthritis. Arthritis Rheumatol. 69, 9–21 (2017).
2. K. H. Collins et al., Obesity, metabolic syndrome, and musculoskeletal disease: Com-
mon inflammatory pathways suggest a central role for loss of muscle integrity. Front.
Physiol. 9, 112 (2018).
3. K. H. Collins et al., Relationship between inflammation, the gut microbiota, and
metabolic osteoarthritis development: Studies in a rat model. Osteoarthritis Cartilage
23, 1989–1998 (2015).
4. K. H. Collins, R. A. Reimer, R. A. Seerattan, T. R. Leonard, W. Herzog, Using diet-
induced obesity to understand a metabolic subtype of osteoarthritis in rats. Osteo-
arthritis Cartilage 23, 957–965 (2015).
5. R. Tang et al., Gene therapy for follistatin mitigates systemic metabolic inflammation
and post-traumatic arthritis in high-fat diet-induced obesity. Sci. Adv. 6, eaaz7492
(2020).
6. T. M. Griffin et al., Diet-induced obesity differentially regulates behavioral, biome-
chanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res. Ther. 12,
R130 (2010).
7. T. M. Griffin, J. L. Huebner, V. B. Kraus, F. Guilak, Extreme obesity due to impaired
leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum. 60,
2935–2944 (2009).
8. N. S. Harasymowicz et al., Intergenerational transmission of diet-induced obesity,
metabolic imbalance, and osteoarthritis in mice. Arthritis Rheumatol. 72, 632–644
(2020).
9. C. L. Wu et al., Dietary fatty acid content regulates wound repair and the patho-
genesis of osteoarthritis following joint injury. Ann. Rheum. Dis. 74, 2076–2083
(2015).
10. P. Y. Mengsteab et al., Mechanically superior matrices promote osteointegration and
regeneration of anterior cruciate ligament tissue in rabbits. Proc. Natl. Acad. Sci.
U.S.A. 117, 28655–28666 (2020).
11. E. Thijssen, A. van Caam, P. M. van der Kraan, Obesity and osteoarthritis, more than
just wear and tear: Pivotal roles for inflamed adipose tissue and dyslipidaemia in
obesity-induced osteoarthritis. Rheumatology (Oxford) 54, 588–600 (2015).
12. X. Wu et al., Contribution of adipose-derived factor D/adipsin to complement alter-
native pathway activation: Lessons from lipodystrophy. J. Immunol. 200, 2786–2797
(2018).
13. C. Xie, Q. Chen, Adipokines: New therapeutic target for osteoarthritis? Curr. Rheu-
matol. Rep. 21, 71 (2019).
14. J. Chang et al., Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis
Cartilage 26, 864–871 (2018).
15. G. Valverde-Franco et al., High in vivo levels of adipsin lead to increased knee tissue
degradation in osteoarthritis: Data from humans and animal models. Rheumatology
(Oxford) 57, 1851–1860 (2018).
16. W. Zou et al., Congenital lipodystrophy induces severe osteosclerosis. PLoS Genet. 15,
e1008244 (2019).
17. Y. Li et al., Fat-produced adipsin regulates inflammatory arthritis. Cell Rep. 27,
2809.e3–2816.e3 (2019).
18. A. Brenot, I. Hutson, C. Harris, Epithelial-adipocyte interactions are required for
mammary gland development, but not for milk production or fertility. Dev. Biol. 458,
153–163 (2020).
19. D. Ferguson, M. Blenden, I. Hutson, Y. Du, C. A. Harris, Mouse embryonic fibroblasts
protect ob/ob mice from obesity and metabolic complications. Endocrinology 159,
3275–3286 (2018).
20. D. B. Burr, E. L. Radin, Microfractures and microcracks in subchondral bone: Are they
relevant to osteoarthrosis? Rheum. Dis. Clin. North Am. 29, 675–685 (2003).
21. K. H. Collins et al., Association of metabolic markers with self-reported osteoarthritis
among middle-aged BMI-defined non-obese individuals: A cross-sectional study. BMC
Obes. 5, 23 (2018).
22. C. L. Wu, K. A. Kimmerling, D. Little, F. Guilak, Serum and synovial fluid lipidomic
profiles predict obesity-associated osteoarthritis, synovitis, and wound repair. Sci.
Rep. 7, 44315 (2017).
23. C. L. Wu et al., Conditional macrophage depletion increases inflammation and does
not inhibit the development of osteoarthritis in obese macrophage fas-induced
apoptosis-transgenic mice. Arthritis Rheumatol. 69, 1772–1783 (2017).
24. C. L. Wu, N. S. Harasymowicz, M. A. Klimak, K. H. Collins, F. Guilak, The role of
macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage 28,
544–554 (2020).
25. D. Hamada et al., Suppressive effects of insulin on tumor necrosis factor-dependent
early osteoarthritic changes associated with obesity and type 2 diabetes mellitus.
Arthritis Rheumatol. 68, 1392–1402 (2016).
26. N. S. Harasymowicz et al., Regional differences between perisynovial and in-
frapatellar adipose tissue depots and their response to class II and class III obesity in
patients with osteoarthritis. Arthritis Rheumatol. 69, 1396–1406 (2017).
27. D. Syx, P. B. Tran, R. E. Miller, A. M. Malfait, Peripheral mechanisms contributing to
osteoarthritis pain. Curr. Rheumatol. Rep. 20, 9 (2018).
28. E. Barboza et al., Profibrotic infrapatellar fat pad remodeling without M1 macro-
phage polarization precedes knee osteoarthritis in mice with diet-induced obesity.
Arthritis Rheumatol. 69, 1221–1232 (2017).
29. Y. Fu, J. L. Huebner, V. B. Kraus, T. M. Griffin, Effect of aging on adipose tissue in-
flammation in the knee joints of F344BN rats. J. Gerontol. A Biol. Sci. Med. Sci. 71,
1131–1140 (2016).
30. W. Liu et al., Effective treatment of steatosis and steatohepatitis by fibroblast growth
factor 1 in mouse models of nonalcoholic fatty liver disease. Proc. Natl. Acad. Sci.
U.S.A. 113, 2288–2293 (2016).
31. M. G. A. Broeren et al., Suppression of the inflammatory response by disease-
inducible interleukin-10 gene therapy in a three-dimensional micromass model of
the human synovial membrane. Arthritis Res. Ther. 18, 186 (2016).
32. I. C. Helmark et al., Exercise increases interleukin-10 levels both intraarticularly and
peri-synovially in patients with knee osteoarthritis: A randomized controlled trial.
Arthritis Res. Ther. 12, R126 (2010).
33. M. Nakata et al., IL-10 gene transfer upregulates arcuate POMC and ameliorates
hyperphagia, obesity and diabetes by substituting for leptin. Int. J. Obes. 40, 425–433
(2016).
34. H. Kondo et al., Interleukin 10 treatment ameliorates high-fat diet-induced inflam-
matory atrial remodeling and fibrillation. Circ. Arrhythm. Electrophysiol. 11, e006040
(2018).
35. S. Lacraz, L. P. Nicod, R. Chicheportiche, H. G. Welgus, J. M. Dayer, IL-10 inhibits
metalloproteinase and stimulates TIMP-1 production in human mononuclear
phagocytes. J. Clin. Invest. 96, 2304–2310 (1995).
36. M. Kapoor, J. Martel-Pelletier, D. Lajeunesse, J. P. Pelletier, H. Fahmi, Role of proin-
flammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol.
7, 33–42 (2011).
37. L. A. Zúñiga et al., IL-17 regulates adipogenesis, glucose homeostasis, and obesity.
J. Immunol. 185, 6947–6959 (2010).
38. L. Chung et al., Interleukin 17 and senescent cells regulate the foreign body response
to synthetic material implants in mice and humans. Sci. Transl. Med. 12, eaax3799
(2020).
39. S. J. B. Snelling et al., Presence of IL-17 in synovial fluid identifies a potential in-
flammatory osteoarthritic phenotype. PLoS One 12, e0175109 (2017).
40. F. Paré et al., In vivo protective effect of adipsin-deficiency on spontaneous knee
osteoarthritis in aging mice. Aging (Albany NY) 12, 2880–2896 (2020).
41. A. Larrañaga-Vera et al., Increased synovial lipodystrophy induced by high fat diet
aggravates synovitis in experimental osteoarthritis. Arthritis Res. Ther. 19, 264 (2017).
42. M. C. Lee et al., CCL17 blockade as a therapy for osteoarthritis pain and disease.
Arthritis Res. Ther. 20, 62 (2018).
43. M. F. Rai, T. Graeve, S. Twardziok, M. F. Schmidt, Evidence for regulated interleukin-4
expression in chondrocyte-scaffolds under in vitro inflammatory conditions. PLoS One
6, e25749 (2011).
44. G. Wirnsberger, D. Hebenstreit, G. Posselt, J. Horejs-Hoeck, A. Duschl, IL-4 induces
expression of TARC/CCL17 via two STAT6 binding sites. Eur. J. Immunol. 36, 1882–1891
(2006).
45. Z. P. Fricker et al., Liver fat is associated with markers of inflammation and oxidative
stress in analysis of data from the framingham heart study. Clin. Gastroenterol
Hepatol. 17, 1157.e4–1164.e4 (2019).
46. S. L. Kolasinski et al., 2019 American college of rheumatology/arthritis foundation
guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis
Rheumatol. 72, 220–233 (2020).
47. D. K. White et al., Daily walking and the risk of incident functional limitation in knee
osteoarthritis: An observational study. Arthritis Care Res. (Hoboken) 66, 1328–1336
(2014).
48. T. M. Griffin, J. L. Huebner, V. B. Kraus, Z. Yan, F. Guilak, Induction of osteoarthritis
and metabolic inflammation by a very high-fat diet in mice: Effects of short-term
exercise. Arthritis Rheum. 64, 443–453 (2012).
49. S. S. Glasson, T. J. Blanchet, E. A. Morris, The surgical destabilization of the medial
meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Car-
tilage 15, 1061–1069 (2007).
50. A. I. Mina et al., CalR: A web-based analysis tool for indirect calorimetry experiments.
Cell Metab. 28, 656–666.e1 (2018).
12 of 12 | PNAS Collins et al.
https://doi.org/10.1073/pnas.2021096118 Adipose tissue is a critical regulator of osteoarthritis
